{
    "nctId": "NCT04708860",
    "briefTitle": "Feasibility of Fasting & Exercise in Pts With HR+ MBC",
    "officialTitle": "Pilot Study of the Impact of a Combined Intermittent Fasting and Exercise Intervention on Metabolic Markers in Patients With Advanced, Hormone Receptor Positive Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Metastatic Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Rate of enrollment",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of ER and/or PR+ metastatic or locally unresectable breast cancer\n* Postmenopausal (including concurrent use of ovarian suppression)\n* Initiating endocrine therapy in combination with:\n\n  * Cohort 1: alpelisib\n  * Cohort 2: palbociclib\n* Self-reported ability to walk two blocks\n* \\> 18 years of age\n* Approval from treating oncologist, confirmed via email or in writing\n* Ability to read and understand English\n\nExclusion Criteria:\n\n* Diagnosis of diabetes requiring medication\n* Engaging in \\>90 minutes of moderate or vigorous physical activity per week",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}